July, 2025 – Medwire

Notice: Function Elementor\Core\Experiments\Manager::warn_removed_or_hidden_dependency was called incorrectly. Feature mega-menu depends on hidden experiment nested-elements. Please see Debugging in WordPress for more information. (This message was added in version 4.3.5.) in /home1/ocasiusm/medwire.ai/wp-includes/functions.php on line 6260
July, 2025 – Medwire

Dexcom Taps Jake Leach as Next CEO

Dexcom has announced that President and COO Jake Leach will become CEO on January 1, 2026, succeeding longtime leader Kevin Sayer. Leach, a 21-year Dexcom

FDA Approves First Neuroimmune Device for Arthritis

SetPoint Medical has received FDA approval for its neuroimmune modulation system, a first-of-its-kind implantable device that treats rheumatoid arthritis (RA) through daily vagus nerve stimulation.

InspireMD has secured approximately $58 million to fuel its next growth phase, while strengthening its leadership with a major board addition.

The funding includes a $40.1M PIPE led by OrbiMed and Marshall Wace, plus $17.9M from warrant exercises. Proceeds will support operations as the company launches

EvoEndo Gains FDA Nod for All-Ages Gastroscope

EvoEndo has received expanded FDA clearance for its Model LE gastroscope, now approved for patients of all ages—from neonates to adults. Previously cleared for ages

Sava Secures $19M to Advance Pain-Free CGM

London-based Sava Technologies has raised $19 million in Series A funding to propel development of its wearable biosensor, a next-gen continuous glucose monitor (CGM). Unlike

Get the MEDWIRE.AI Newsletter

Stay ahead in MedTech with industry updates, breakthroughs, and expert
insights—delivered straight to your inbox.

© 2025 MEDWIRE.AI. All rights reserved. MEDWIRE.AI is a trusted source for MedTech news and insights. Our website content and services are for informational purposes only. MEDWIRE.AI does not provide medical advice, diagnosis, or treatment.